This bid is closed — responses were due June 18, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This grant opportunity, PAR-25-157, supports cutting-edge technologies for translational science. It is an R21 grant, and clinical trials are not allowed. The CFDA number is 93.350.
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.